Description
[ CAS NO. ] 168273-06-1
[ Molecular Formula ] C22H21Cl3N4O
[ Molecular Weight ] 463.79
[ Appearance ] White crystal powder
[ Application ]
A new type of weight loss drug, and can be applied to smoking cessation.
About Rimonabant
Rimonabant is the world’s first type 1 cannabinoid receptor (CB1) inhibitor type weight loss drug, which has a good weight loss effect, and has the effect of sensitizing insulin and improving lipid metabolism disorders. Smoking cessation effect. It was approved for marketing in the European Union in 2006 as a new type of weight loss drug. However, some studies have shown that rimonabant can increase the serious adverse effects of mental aspects, namely depression and anxiety. FDA data show that rimonabant can increase the risk of suicide in users. The clinical use of rimonabant was discontinued in 2009 due to serious adverse psychiatric effects.
